Phospho-TSC1 (Ser505) Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
Hamartin, or TSC1, is a suspected tumor suppressor implicated in the disease tuberous sclerosis 1. It is a negative regulator of cell division controlling the transition from G0/G1 to S phase, and it seems to act through the phosphatidylinositol 3 kinase/Akt pathway. TSC1 interacts with tuberin m (TSC2), which is thought to be a GAP (GTPase Activating Protein) for the Rap1 and Rab5 small G Proteins. The Hamartin/Tuberin complex has been shown to inhibit mTor. Hamartin has also been shown to interact with ERM (Ezrin-Radixin-Moesin) proteins and with F-actin, suggesting a role for TSC proteins in modulation of cell adhesion and morphology.
Synonyms
TSC1phospho S505; LAM; TSC1; Tuberous sclerosis 1 protein.
Gene ID
7248
Modification Site
Ser505
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
Phospho-TSC1 (Ser505)
Clonality
Polyclonal
Conjugation
PE-Cy7
Source
KLH conjugated synthetic phosphopeptide derived from human TSC1 around the phosphorylation site of Ser505 [FD (p-S) PF]
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1ug/ul
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Prediction Reactivity
Rat, Dog, Cow, Pig, Horse, Chicken, Rabbit
Gene ID URL
7248
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
360211-01 50 µL
F11 (Coagulation Factor XI, FXI, Plasma Thromboplastin antecedent, PTA) discontinued
Ask
View Details 
360211-02 100 µL
F11 (Coagulation Factor XI, FXI, Plasma Thromboplastin antecedent, PTA) discontinued
Ask
View Details